Thérapies de Conversion

Pratiques visant à modifier l'orientation sexuelle ou l'identité de genre, illégales en France depuis la loi n°2022-92, et leurs effets psychologiques documentés.

500 articles disponibles

conversion therapy
sexual orientation change effort
SOCE harm
gender identity conversion
reparative therapy mental health
ex-gay therapy
conversion practice religious

"Praying in or preying on my skin": a narrative study of transgender and gender non-conforming individuals' experiences with religion and gender identity in India.

This narrative analysis paper explores how gender non-conforming individuals interact with faith across Indian religious traditions. Drawing upon four in-depth semi-structured interviews with the part…

Neurosciences des Croyances Thérapies de Conversion
Ashok, S., & Saranya, T. S. (2025). "Praying in or preying on my skin": a narrative study of transgender and gender non-conforming individuals' experiences with religion and gender identity in India.. Front Sociol, 10, 1642404. https://doi.org/10.3389/fsoc.2025.1642404

Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature.

BACKGROUND: Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer (GC) characterized by alpha-fetoprotein (AFP) production and invasive liver and lymph node metastases, typi…

Thérapies de Conversion
Li, Y., Wang, Y., Yu, T., Wang, D., Ma, H., Ma, J., & Da, M. (2025). Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature.. Front Oncol, 15, 1648766. https://doi.org/10.3389/fonc.2025.1648766

Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis.

BACKGROUND: Transarterial chemoembolization (TACE) is a potential conversion therapeutic strategy for unresectable hepatocellular carcinoma (uHCC). However, therapeutic options following conversion th…

Thérapies de Conversion
Hu, J., Zhao, S., Zuo, M., Li, C. H., Yao, W., Yang, X., Xing, W., & Song, P. (2025). Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis.. Ther Adv Med Oncol, 17, 17588359251316665. https://doi.org/10.1177/17588359251316665

Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring exon 20 insertion.

This case study details an innovative conversion therapy strategy in a 58-year-old Asian male with baseline stage cTNM advanced lung squamous cell carcinoma (SCC) harboring a rare exon 20 insertion m…

Thérapies de Conversion
Xu, M., Huo, X., Zhang, C., Zhang, X., Wang, H., Yang, H., Ge, N., Wang, Y., & Hou, H. (2024). Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring exon 20 insertion.. Hum Vaccin Immunother, 20(1), 2431384. https://doi.org/10.1080/21645515.2024.2431384

Non-surgery strategy versus hepatectomy in hepatocellular carcinoma patients with complete response after conversion therapy: a meta-analysis.

BACKGROUND: There is ongoing debate surrounding the optimal therapeutic strategy for hepatocellular carcinoma (HCC) patients achieving complete response (CR) after conversion therapy. This meta-analys…

Thérapies de Conversion
Wang, J., Hu, Y., Zhou, L., Yang, Y., Chen, J., Chen, H., & Wang, H. (2024). Non-surgery strategy versus hepatectomy in hepatocellular carcinoma patients with complete response after conversion therapy: a meta-analysis.. World J Surg Oncol, 22(1), 349. https://doi.org/10.1186/s12957-024-03645-6

Association of PD-1 + Treg/PD-1 + CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatment.

BACKGROUND: Recent studies have highlighted the distinct ratio of PD-1 + Treg/PD-1 + CD8 for prognosis prediction. However, it remains unclear about the association of this ratio and tertiary lymphoid…

Thérapies de Conversion
Liu, X., Xu, D., Zhou, C., Zhong, Y., Geng, H., Huang, C., Shen, Y., Xia, X., Wang, C., Zhu, C., & Cao, H. (2024). Association of PD-1 + Treg/PD-1 + CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatment.. J Transl Med, 22(1), 1152. https://doi.org/10.1186/s12967-024-05867-4

Supporting autonomy in young people with gender dysphoria: psychotherapy is not conversion therapy.

Opinion is divided about the certainty of the evidence base for gender-affirming medical interventions in youth. Proponents claim that these treatments are well supported, while critics claim the poor…

Thérapies de Conversion
D'Angelo, R. (2024). Supporting autonomy in young people with gender dysphoria: psychotherapy is not conversion therapy.. J Med Ethics, 51(1), 3-9. https://doi.org/10.1136/jme-2023-109282

Therapeutic types and advantages of functionalized nanoparticles in inducing ferroptosis in cancer therapy.

BACKGROUND: The clinical efficacy of cancer treatment protocols remains unsatisfactory; however, the emergence of ferroptosis-driven therapy strategies has renewed hope for tumor treatment, owing to t…

Thérapies de Conversion
Wang, Z., Zhao, M., Huang, X., Wang, Y., Li, W., Qiao, J., & Yang, X. (2024). Therapeutic types and advantages of functionalized nanoparticles in inducing ferroptosis in cancer therapy.. Ann Med, 56(1), 2396568. https://doi.org/10.1080/07853890.2024.2396568

A Case of Fibrolamellar Hepatocellular Carcinoma in Which Tumor Control Was Achieved by Re-Administering Atezolizumab and Bevacizumab.

BACKGROUND: Fibrolamellar hepatocellular carcinoma (FL-HCC) clinically occurs in young people aged 20-30 years, who often have a normal liver background. We propose a treatment for such cases in which…

Thérapies de Conversion
Hagiwara, S., Oda, I., Ueshima, K., Komeda, Y., Nishida, N., Yoshida, A., Yamamoto, T., Omaru, N., Matsubara, T., & Kudo, M. (2024). A Case of Fibrolamellar Hepatocellular Carcinoma in Which Tumor Control Was Achieved by Re-Administering Atezolizumab and Bevacizumab.. Cancer Rep (Hoboken), 7(12), e70090. https://doi.org/10.1002/cnr2.70090

Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.

Recent advances in systemic therapy for hepatocellular carcinoma (HCC) have led to debates about the feasibility of combination therapies, such as systemic therapy combined with surgery or transarteri…

Thérapies de Conversion
Akahoshi, K., Shindoh, J., Tanabe, M., Ariizumi, S., Eguchi, S., Okamura, Y., Kaibori, M., Kubo, S., Shimada, M., Taketomi, A., Takemura, N., Nagano, H., Nakamura, M., Hasegawa, K., Hatano, E., Yoshizumi, T., Endo, I., & Kokudo, N. (2024). Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.. Liver Cancer, 13(6), 0-10. https://doi.org/10.1159/000538627

Efficacy of sintilimab combined with neoadjuvant chemotherapy and trastuzumab in conversional treatment of locally advanced HER2-positive gastric cancer: case analysis and literature review.

BACKGROUND: Regional lymph nodes that are fixed and fused into clusters or those exhibiting metastases outside the regional lymph nodes are generally classified as stage IV (M1) or unresectable. Patie…

Thérapies de Conversion
Ibrahim, S., Maimaitiaili, A., Zhu, G., & Ye, S. (2024). Efficacy of sintilimab combined with neoadjuvant chemotherapy and trastuzumab in conversional treatment of locally advanced HER2-positive gastric cancer: case analysis and literature review.. J Cancer Res Clin Oncol, 150(12), 507. https://doi.org/10.1007/s00432-024-06024-6

Complete pathological response in a patient with locally advanced rectal cancer following conversion therapy: A case report.

Thérapies de Conversion
Xue, Y., Zhao, Y., Dong, B., & Yang, X. (2024). Complete pathological response in a patient with locally advanced rectal cancer following conversion therapy: A case report.. Asian J Surg. https://doi.org/10.1016/j.asjsur.2024.10.070
Loading…
Loading the web debug toolbar…
Attempt #